EPS for Cantel Medical Corp. (CMD) Expected At $0.62

September 8, 2018 - By Victoria Pittman

Analysts expect Cantel Medical Corp. (NYSE:CMD) to report $0.62 EPS on September, 27.They anticipate $0.08 EPS change or 14.81 % from last quarter’s $0.54 EPS. CMD’s profit would be $25.86M giving it 38.87 P/E if the $0.62 EPS is correct. After having $0.60 EPS previously, Cantel Medical Corp.’s analysts see 3.33 % EPS growth. The stock increased 2.00% or $1.89 during the last trading session, reaching $96.39. About 176,860 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 69.41% since September 8, 2017 and is uptrending. It has outperformed by 56.84% the S&P500.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $4.02 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 44.22 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Cantel Medical Corp. (NYSE:CMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.